Again, tirzepatide appears to be more potent, generating average losses of approximately 20% at the highest doses (10 and 15 mg/week) administered for 72 weeks (Figure 5B)
20, 2025 from Shankar, G., Arkin, S., Cocea, L., et al
doi:10.1111/dom.14725 15.Wilding JPH, Batterham RL, Kandler K, Davies M, Van Gaal LF, Lingvay I
At Atrium Medical, GLP-1 care can combine in-person evaluation, labs, vitals, side-effect assessment, insurance documentation, and televisit follow-up when appropriate
Powerful Blood Sugar Control The primary benefit of Semaglutide lies in its ability to effectively control blood sugar levels in people with type 2 diabetes by increasing the levels of insulin in the body